X-37 has closed a $14.5 million Series A financing, led by DCVC Bio and joined by Alpha Intelligence Capital and Hemi Ventures. X-37 was cofounded by AtomWise and an experienced team of pharmaceutical developers from Velocity Pharmaceutical Development. With AtomWise’s top #AI platform, we have already generated promising hits against ZAP-70 for autoimmune diseases, PIM3 and SHP2 for #cancer, and Factor XIIa #anticoagulation.


Pharmaceutical

X37's headquarters in South San Francisco, CA, United States

David Collier

Anie Roche

Andrew Pearlman

David Gluckman

Antoine Blondeau

Abraham Heifets

Kiersten Stead

X37's Leadership Team includes Andrew Pearlman and 4 others.

About

People (4)

Andrew Pearlman

Anie Roche

Ed Schnipper

James Larrick

Jobs